Clearstead Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.05M | Sell |
6,212
-926
| -13% | -$503K | 0.03% | 296 |
|
|
2025
Q4 | $4.14M | Sell |
7,138
-207
| -3% | -$117K | 0.05% | 228 |
|
|
2025
Q3 | $3.56M | Buy |
7,345
+88
| +1% | +$41K | 0.05% | 234 |
|
|
2025
Q2 | $2.94M | Sell |
7,257
-638
| -8% | -$267K | 0.04% | 263 |
|
|
2025
Q1 | $3.93M | Sell |
7,895
-20
| -0.3% | -$10.8K | 0.06% | 207 |
|
|
2024
Q4 | $4.12M | Sell |
7,915
-56
| -0.7% | -$30.8K | 0.06% | 202 |
|
|
2024
Q3 | $4.93M | Buy |
7,971
+256
| +3% | +$152K | 0.08% | 185 |
|
|
2024
Q2 | $4.27M | Buy |
7,715
+1,763
| +30% | +$1.01M | 0.07% | 190 |
|
|
2024
Q1 | $3.52M | Buy |
5,952
+411
| +7% | +$231K | 0.17% | 103 |
|
|
2023
Q4 | $2.94M | Sell |
5,541
-6,833
| -55% | -$3.31M | 0.16% | 116 |
|
|
2023
Q3 | $6.26M | Buy |
12,374
+7,471
| +152% | +$3.98M | 0.18% | 101 |
|
|
2023
Q2 | $2.56M | Buy |
4,903
+320
| +7% | +$173K | 0.16% | 111 |
|
|
2023
Q1 | $2.64M | Buy |
4,583
+1,606
| +54% | +$905K | 0.19% | 95 |
|
|
2022
Q4 | $1.64M | Buy |
2,977
+423
| +17% | +$224K | 0.13% | 133 |
|
|
2022
Q3 | $1.3M | Buy |
2,554
+316
| +14% | +$177K | 0.12% | 142 |
|
|
2022
Q2 | $1.22M | Sell |
2,238
-207
| -8% | -$114K | 0.09% | 158 |
|
|
2022
Q1 | $1.44M | Buy |
2,445
+558
| +30% | +$321K | 0.1% | 150 |
|
|
2021
Q4 | $1.26M | Buy |
1,887
+782
| +71% | +$488K | 0.09% | 161 |
|
|
2021
Q3 | $631K | Sell |
1,105
-24
| -2% | -$13.2K | 0.05% | 217 |
|
|
2021
Q2 | $570K | Sell |
1,129
-14
| -1% | -$6.61K | 0.04% | 212 |
|
|
2021
Q1 | $522K | Buy |
1,143
+457
| +67% | +$218K | 0.04% | 209 |
|
|
2020
Q4 | $320K | Hold |
686
| – | – | 0.03% | 258 |
|
|
2020
Q3 | $303K | Sell |
686
-470
| -41% | -$194K | 0.03% | 231 |
|
|
2020
Q2 | $419K | Hold |
1,156
| – | – | 0.05% | 192 |
|
|
2020
Q1 | $328K | Sell |
1,156
-470
| -29% | -$148K | 0.05% | 188 |
|
|
2019
Q4 | $528K | Buy |
1,626
+470
| +41% | +$143K | 0.06% | 175 |
|
|
2019
Q3 | $337K | Sell |
1,156
-268
| -19% | -$76.7K | 0.05% | 206 |
|
|
2019
Q2 | $418K | Hold |
1,424
| – | – | 0.06% | 187 |
|
|
2019
Q1 | $390K | Buy |
1,424
+45
| +3% | +$11.2K | 0.05% | 189 |
|
|
2018
Q4 | $309K | Sell |
1,379
-619
| -31% | -$145K | 0.05% | 200 |
|
|
2018
Q3 | $488K | Hold |
1,998
| – | – | 0.07% | 156 |
|
|
2018
Q2 | $414K | Hold |
1,998
| – | – | 0.06% | 160 |
|
|
2018
Q1 | $413K | Buy |
1,998
+150
| +8% | +$31.5K | 0.06% | 153 |
|
|
2017
Q4 | $351K | Sell |
1,848
-150
| -8% | -$28.7K | 0.05% | 166 |
|
|
2017
Q3 | $378K | Sell |
1,998
-927
| -32% | -$168K | 0.05% | 176 |
|
|
2017
Q2 | $510K | Buy |
2,925
+320
| +12% | +$53.8K | 0.07% | 148 |
|
|
2017
Q1 | $400K | Buy |
+2,605
| New | +$398K | 0.06% | 156 |
|
Other funds holding TMO
VCM
Clearstead Advisors's TMO Position: Q1 2026 in Review
Clearstead Advisors reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q1 2026, selling an estimated $503K and leaving 6,212 shares worth $3.05M. The position accounts for 0.03% of the portfolio, ranked #296.
Clearstead Advisors first reported a position in TMO in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.26M in Q3 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Clearstead Advisors held 6,212 shares of Thermo Fisher Scientific worth $3.05M as of Q1 2026.
- Clearstead Advisors sold 926 Thermo Fisher Scientific shares in Q1 2026, an estimated $503K.
- Thermo Fisher Scientific made up 0.03% of Clearstead Advisors's portfolio in Q1 2026, its #296 holding.
- Clearstead Advisors first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 37 quarters since.
- Clearstead Advisors's Thermo Fisher Scientific position peaked at $6.26M in Q3 2023.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.